HIM
RDY icon

Hillsdale Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Hillsdale Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-650
Closed -$9K – 656
2020
Q4 		$9K Hold
650
– – ﹤0.01% 505
2020
Q3 		$9K Sell
650
-100
-13% -$1.19K ﹤0.01% 501
2020
Q2 		$8K Hold
750
– – ﹤0.01% 487
2020
Q1 		$6K Buy
+750
New +$6.25K ﹤0.01% 515

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hillsdale Investment Management's RDY Position: Q1 2021 in Review

Hillsdale Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 650 shares — an estimated $9K sold.

Hillsdale Investment Management first reported a position in RDY in Q1 2020 and held it in 4 quarters. The position peaked at $9K in Q4 2020. 161 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

  • Hillsdale Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
  • Hillsdale Investment Management sold 650 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $9K.
  • Hillsdale Investment Management first reported a position in Dr. Reddy's Laboratories in Q1 2020 and held it in 4 quarters.
  • Hillsdale Investment Management's Dr. Reddy's Laboratories position peaked at $9K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Hillsdale Investment Management's 13F filing for Q1 2021, filed 22 Apr 2021.